Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.230 -0.580 (-12.06%)
Streaming Delayed Price Updated: 1:30 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia’s AI Explosion: What NVDA Stock Investors Need to Know Now
Rather than sell your Nvidia shares, diversify. That's what the Cloud Czars want to do. They'll save, and you'll profit. 
Via InvestorPlace
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Where Recursion Pharmaceuticals Stands With Analysts
Via Benzinga
These 26 AI Stocks Are Up 58% In Just 11 Weeks
The Bank of America suggests that this is just a 
Via Talk Markets
MarketBeat Week in Review – 7/17 - 7/21
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
They're not guaranteed to keep soaring, but they are right now. 
Via The Motley Fool
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?
Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week. 
Via InvestorPlace
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why It May Not Be Too Late to Join Nvidia’s Sky-High AI Rally
As long as Nvidia is a darling of the market - and as long as the company invests in future-facing technology - NVDA stock has room to run. 
Via InvestorPlace
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
Both companies could tap into huge growth from the AI revolution in a few years. 
Via The Motley Fool
NVIDIA Just Invested $50 Million in This Biotech -- Should You Buy It?
Gaining one of the world's most important AI companies as a collaborator is huge. 
Via The Motley Fool
NVDA Stock Update: What Nvidia Investors Need to Be Watching Now
With Nvidia still the best option for long-term investors looking to take advantage of the AI race, here's what to watch. 
Via InvestorPlace
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Biotech Stocks Using AI to Change Healthcare Forever
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About
Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. 
Via Benzinga
Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia)
The small biotech is enjoying the rewards of being linked to one of the hottest AI giants around. 
Via The Motley Fool
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?
RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment. 
Via InvestorPlace
Why Recursion Pharmaceuticals (RXRX) Stock Is Falling Thursday
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares are trading lower on Thursday as traders appear to be taking profits. The stock rallied on Wednesday after the company announced a $50 m 
Via Benzinga
Top Trending Stocks: Recursion Pharmaceuticals, Beyond Meat, Tesla, Disney, NIO in Focus
Via Benzinga
Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket
Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday. 
Via The Motley Fool
RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring
Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock. 
Via InvestorPlace
Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&P 500,... 
Via Benzinga
Recursion Pharmaceuticals (NASDAQ: RXRX) Forms Powerful Partnership with NVIDIA (NASDAQ: NVDA)
A $50 Million Investment to Boost AI Capabilities in Drug Discovery Recursion Pharmaceuticals (NASDAQ: RXRX), a trailblazer in TechBio that 
Via Spotlight Growth
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks Extend Rally On Cooler-Than-Expected CPI Reading
The S&P 500 Index and Nasdaq Composite sport solid midday leads, as investors hope the data may push the Federal Reserve away from more interest rate hikes. 
Via Talk Markets
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
Why Recursion Pharmaceuticals Stock is Skyrocketing Today?
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are trading higher after the company announced a $50 million investment by NVIDIA Corporation (NASDAQ: NVDA), executed as a private  
Via Benzinga
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected
U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.